AM
Andrea Mastrangelo
University of Bologna
Research areas: Medicine · Psychiatry and Mental health · Dementia and Cognitive Impairment Research · Alzheimer's disease research and treatments · Parkinson's Disease Mechanisms and Treatments
0000-0003-1578-8112
Employment
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (28)
- Characterization of patients with isolated REM sleep behavior disorder and cerebrospinal fluid α-synuclein negativity Save
- Clinical correlates of a negative cerebrospinal fluid α-synuclein seed amplification assay result in Parkinson’s disease Save
- Prevalence and clinical effects of Lewy Body pathology in non-prion rapidly progressive dementias: a retrospective cohort study Save
- CSF1R mutations in an Italian population of early-onset dementia: a case series Save
- A comparison of p-tau assays for the specificity to detect tau changes in Alzheimer's disease Save
- Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum Save
- Clinical and radiological stabilization following vutrisiran treatment in transthyretin leptomeningeal amyloidosis: a case report Save
- Clinical value of novel blood-based tau biomarkers in Creutzfeldt–Jakob disease Save
- Distinct cerebrospinal fluid proteomic signatures define clinicopathological subtypes of sporadic Creutzfeldt-Jakob disease and predict patient survival Save
- Head-to-head comparison of four cerebrospinal fluid and three plasma neurofilament light chain assays in Parkinsonism Save
- Quantification of Lewy body pathology by cerebrospinal fluid endpoint dilution RT-QuIC in a neuropathological autopsy cohort of clinically heterogeneous participants Save
- Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson’s disease Save
- Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity? Save
- Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia Save
- Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden Save
- Progressive Ataxia and Palatal Tremor Is Not Associated with IgLON5 Antibodies: Results From Two Cases Save
- Tracking neurodegenerative diseases in biofluids: Combining pathology and pathophysiology markers is the way Save
- Levels of plasma brain‐derived tau and p‐tau181 in Alzheimer's disease and rapidly progressive dementias Save
- Amyloid-Beta Co-Pathology Is a Major Determinant of the Elevated Plasma GFAP Values in Amyotrophic Lateral Sclerosis Save
- Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias Save